Stockreport

Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF Initiates Strategic Repositioning to Focus on Company’s Core RNA Delivery Technology Altamira Therapeutics retains 49% in Altamira Medica AG, and secures 25% [Read more]